Do Analysts Expect Acutus Medical Inc (AFIB) Stock to Rise After It Is Lower By 0.00% in a Month?

Wall Street is positive on Acutus Medical Inc (AFIB). On average, analysts give AFIB a Hold rating. The average price target is $2.25, which means analysts expect the stock to rise by 48.03% over the next twelve months. That average ranking earns AFIB an Analyst Rating of 5, which is better than 5% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating AFIB a Hold today. Find out what this means to you and get the rest of the rankings on AFIB!

See Full AFIB Report

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Acutus Medical Inc Stock Today?

Acutus Medical Inc (AFIB) stock is trading at $1.52 as of 3:37 PM on Friday, Aug 5, a rise of $0.04, or 2.7% from the previous closing price of $1.48. The stock has traded between $1.43 and $1.56 so far today. Volume today is below average. So far 509,777 shares have traded compared to average volume of 6,633,716 shares. Click Here to get the full Stock Report for Acutus Medical Inc stock.